BridgeMD
New treatment option for Alcohol Withdrawal
Official title Use of tAN® in Alcohol Withdrawal Management
ClinicalTrials.gov ID: NCT06771037
What this study is testing
- What it's testing
- This research study is being conducted to learn if Transcutaneous Auricular Neurostimulation (tAN®) may be effective in treating alcohol withdrawal syndrome. Transcutaneous Auricular Neurostimulation (tAN®) works by delivering small electrical stimulations to the Vagus and Trigeminal nerves.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Ages 18 years old to 65 years old
- Entering an inpatient substance use treatment program for alcohol withdrawal management.
- Score a 27 or higher on the WHO-ASSIST V3.0
- Is proficient in English
- Score of a 4 or higher on the Prediction of Alcohol Withdrawal Severity Scale (PAWSS)
You likely can't join if
- Age \ 65
- Requires medical tapering from benzodiazepines or opioids.
- Has a history of epileptic seizures or seizures due to alcohol withdrawal.
- Has a cardiac pacemaker, cochlear prosthesis, neurostimulator or other device for which tAN® would be contraindicated.
- Has abnormal ear anatomy or an ear infection is present.
- Is pregnant.
See the full eligibility criteria
- Ages 18 years old to 65 years old
- Entering an inpatient substance use treatment program for alcohol withdrawal management.
- Score a 27 or higher on the WHO-ASSIST V3.0
- Is proficient in English
- Score of a 4 or higher on the Prediction of Alcohol Withdrawal Severity Scale (PAWSS)
- Able to provide written informed consent.
- Stated willingness to comply with all study procedures and availability for the duration of the study.
- Age \ 65
- Requires medical tapering from benzodiazepines or opioids.
- Has a history of epileptic seizures or seizures due to alcohol withdrawal.
- Has a cardiac pacemaker, cochlear prosthesis, neurostimulator or other device for which tAN® would be contraindicated.
- Has abnormal ear anatomy or an ear infection is present.
- Is pregnant.
- Has any serious medical disease or condition which, in the judgment of the Principal Investigator or his/her designee, would make study participation unsafe, or would make intervention compliance difficult.
The study team makes the final eligibility decision.
Where it's taking place
- Wernersville, Pennsylvania, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wernersville, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.